Xtx Topco LTD Infinity Pharmaceuticals, Inc. Transaction History

Xtx Topco LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.01 - $0.24 $1,810 - $43,456	181,068 New	181,068 $3,000
Q2 2022 Aug 15, 2022	SELL	$0.49 - $1.2 $18,874 - $46,222	-38,519 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$0.85 - $2.4 $111 - $314	-131 Reduced 0.34%	38,519 $44,000
Q4 2021 Feb 11, 2022	BUY	$1.86 - $3.36 $37,979 - $68,607	20,419 Added 112.0%	38,650 $87,000
Q3 2021 Nov 12, 2021	BUY	$1.52 - $3.82 $27,711 - $69,642	18,231 New	18,231 $62,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.